Mechanistically, PCDHGC3 knockdown activated mTOR signaling, leading to aberrant HIF2α stabilization, a well-established oncogenic driver in ccRCC. This evidence concerns the gene PCDHGC3 and nonpapillary renal cell carcinoma.